Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 5
1993 3
1994 4
1995 8
1996 8
1997 9
1998 8
1999 5
2000 15
2001 16
2002 7
2003 16
2004 12
2005 12
2006 21
2007 21
2008 9
2009 22
2010 25
2011 35
2012 30
2013 41
2014 45
2015 33
2016 29
2017 46
2018 35
2019 33
2020 47
2021 39
2022 35
2023 32
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Results by year

Filters applied: . Clear all
Page 1
Drug repurposing: progress, challenges and recommendations.
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M. Pushpakom S, et al. Among authors: pirmohamed m. Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12. Nat Rev Drug Discov. 2019. PMID: 30310233 Review.
Immunogenicity to biologics: mechanisms, prediction and reduction.
Sethu S, Govindappa K, Alhaidari M, Pirmohamed M, Park K, Sathish J. Sethu S, et al. Among authors: pirmohamed m. Arch Immunol Ther Exp (Warsz). 2012 Oct;60(5):331-44. doi: 10.1007/s00005-012-0189-7. Epub 2012 Aug 29. Arch Immunol Ther Exp (Warsz). 2012. PMID: 22930363 Free article. Review.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
Johnson JA, Caudle KE, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, Lee MT, Gage BF, Kimmel SE, Perera MA, Anderson JL, Pirmohamed M, Klein TE, Limdi NA, Cavallari LH, Wadelius M. Johnson JA, et al. Among authors: pirmohamed m. Clin Pharmacol Ther. 2017 Sep;102(3):397-404. doi: 10.1002/cpt.668. Epub 2017 Apr 4. Clin Pharmacol Ther. 2017. PMID: 28198005 Free PMC article.
Monitoring drug treatment.
Pirmohamed M, Ferner RE. Pirmohamed M, et al. BMJ. 2003 Nov 22;327(7425):1179-81. doi: 10.1136/bmj.327.7425.1179. BMJ. 2003. PMID: 14630730 Free PMC article. No abstract available.
Pharmacogenetics and pharmacogenomics.
Pirmohamed M. Pirmohamed M. Br J Clin Pharmacol. 2001 Oct;52(4):345-7. doi: 10.1046/j.0306-5251.2001.01498.x. Br J Clin Pharmacol. 2001. PMID: 11678777 Free PMC article. No abstract available.
Pharmacogenetics of Adverse Drug Reactions.
Osanlou O, Pirmohamed M, Daly AK. Osanlou O, et al. Among authors: pirmohamed m. Adv Pharmacol. 2018;83:155-190. doi: 10.1016/bs.apha.2018.03.002. Adv Pharmacol. 2018. PMID: 29801574 Review.
New Approaches to Investigate Drug-Induced Hypersensitivity.
Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ. Ogese MO, et al. Among authors: pirmohamed m. Chem Res Toxicol. 2017 Jan 17;30(1):239-259. doi: 10.1021/acs.chemrestox.6b00333. Epub 2016 Nov 15. Chem Res Toxicol. 2017. PMID: 27806199 Review.
Herbal medicines.
Pirmohamed M. Pirmohamed M. Postgrad Med J. 2003 Sep;79(935):489. doi: 10.1136/pmj.79.935.489. Postgrad Med J. 2003. PMID: 13679543 Free PMC article. No abstract available.
Adverse drug reactions.
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Pirmohamed M, et al. BMJ. 1998 Apr 25;316(7140):1295-8. doi: 10.1136/bmj.316.7140.1295. BMJ. 1998. PMID: 9554902 Free PMC article. Review. No abstract available.
648 results